Stocktoria
Definium Therapeutics, Inc. DFTX
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04
Definium Therapeutics, Inc. statistics & valuation
Market cap$4.9B
P / B14.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -41.8% | -36.0% | -76.9% | -33.4% | -56.7% |
| Return on equity | -55.3% | -45.0% | -122.5% | -37.6% | -61.3% |
| Debt / equity | 0.12× | 0.09× | 0.18× | — | — |
| Current ratio | 6.29 | 7.25 | 3.22 | 8.16 | 13.18 |
Source: SEC EDGAR filings · CIK 0001813814 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.